Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus.
Army Contracting Command ordered additional filled drug production doses of the mRNA-1273 vaccine from the biotechnology firm by using the first option and acetate-related efforts under a previously awarded contract, the Department of Defense said Monday.
Cambridge, Massachusetts-based Moderna developed the vaccine with the National Institute of Allergy and Infectious Diseases and received an emergency use authorization from the Food and Drug Administration on Dec. 18.
The company received the full amount of the award and is expected to finish work under the modification by June 30.
DOD and the Department of Health and Human Services signed a $1.5B deal with Moderna in August to procure 100M initial vaccine doses of the vaccine.
The deputy secretary of DHS addressed Potomac Officers Club’s annual GovCon-focused summit and discussed integration, data flow, speed.
Moak previously served as senior vice president for U.S. public sector sales at Exiger.
Mike Deutsch, most recently chief growth officer at Alpha Omega, has been named the company’s chief strategy officer to lead…
FishEye brings nearly 30 years of experience supporting government-owned missile defense and space domain awareness radars to LeoLabs.
GSA has named 24 companies for Phase 2 awards under the Alliant 3 GWAC, with the next round expected in…
The Army is preparing a $249 million multiple-award competition for aviation training teams supporting foreign military sales.
The new CS Federal VP brings experience in proposal development, digital marketing and enterprise innovation.
Kelly Baltz and Craig Janus lead the National Security Systems and Defense Mission Systems divisions, respectively.
Redhorse has acquired KDA Consulting, an IC cloud and AI enablement firm, to expand its cyber and data offerings for…
Brian Snell, director of the Broadcom software business at Carahsoft, has urged agencies to balance data protection and AI enablement.
CLEATUS co-founder Yigit Guney, a GovCon Expert, reveals that 45 percent of FY2026 federal solicitations were amended after release.
The work supports U.S. Special Operations Command Pacific and runs through September 2033.
You’ve already read all related articles.
VIDEO